From: Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study
No of females
54.4% (149/125)
Median age in years
35 (32 – 42)
Median CD4 at baseline (n = 251)
174 (107 – 265)
Median log10 VL at baseline (n = 261)
4.1 (3.6 – 4.7)
Median no of months followed up
27 (15 – 47)